A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development

R. Romaszkiewicz, J. Lewczuk, P. Piszko, A. Wahab Ajlan, B. Ludwik, B. Sobkowicz, K. Wrabec (Wroclaw, Poland)

Source: Annual Congress 2003 - Pulmonary thromboembolism

Session: Pulmonary thromboembolism
Session type: Poster Discussion
Number: 1487

Disease area: Pulmonary vascular diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Romaszkiewicz, J. Lewczuk, P. Piszko, A. Wahab Ajlan, B. Ludwik, B. Sobkowicz, K. Wrabec (Wroclaw, Poland). A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development. Eur Respir J 2003; 22: Suppl. 45, 1487

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)? Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011
Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018
Long-term outcomes of pulmonary endarterectomy (PEA) for chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2007; 30: Suppl. 51, 603s Year: 2007
Accuracy of pre-operative specimen level prediction in chronic thromboembolic pulmonary hypertension (CTEPH) patients undergoing pulmonary thromboendarterectomy (PTE) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH Year: 2012
The effect of pulmonary thromboendarterectomy (PTE) on dead space ventilation in patients with chronic thrombo embolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2004; 24: Suppl. 48, 404s Year: 2004
Pulmonary embolism and the consequences for the right heart Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136 Year: 2006
Surgical and post-operative treatment of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2009; 19: 64-67 Year: 2010
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
The course of chronic thromboembolic pulmonary hypertension (CTEPH) in anticoagulated patients not eligible for pulmonary endarterectomy Source: Eur Respir J 2002; 20: Suppl. 38, 237s Year: 2002
Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2009 - Pulmonary embolism Year: 2009
Pulmonary artery pulse pressure in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2006; 28: Suppl. 50, 399s Year: 2006
Newly diagnosed patients with chronic thromboembolic pulmonary hypertension and PASP<50 mmHg. Do they need pulmonary endarterectomy? Source: Annual Congress 2005 - News about pulmonary embolism Year: 2005
Impact of two 5-year anticoagulant strategies on survival and echocardiographic parameters in the patients with chronic thromboembolic pulmonary hypertension (CTEPH) who did not undergo pulmonary endarterectomy Source: Annual Congress 2004 - Pulmonary embolism Year: 2004
Survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005
Initial dual oral combination therapy prior to pulmonary endarterectomy (PEA) in patients with operable chronic thromboembolic pulmonary hypertension (CTEPH) and high preoperative pulmonary vascular resistance (PVR) Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension Year: 2020
The influence of fractional pulse pressure on the outcome of pulmonary thromboendarterectomy Source: Eur Respir J 2001; 17: 653-659 Year: 2001
Mismatch of major vessel obstruction and pulmonary vascular resistance (PVR) in chronic thromboembolic pulmonary hypertension (CTEPH) with associated medical conditions (AMC) Source: Eur Respir J 2006; 28: Suppl. 50, 402s Year: 2006
Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009